BioWorld - Monday, June 8, 2026

BioWorld Science

Aug. 24, 2021

View Archived Issues

New SUMO-activating enzyme subunit 1 inhibitors identified at Oncovalent Therapeutics

Read More

Icahn School of Medicine at Mount Sinai presents new arylsulfonamide derivatives

Read More

New NLRP3 inflammasome inhibitors patented by Roche, Genentech

Read More

Suzhou Ark Biopharmaceutical patents respiratory syncytial virus inhibitors

Read More

Rhenium-labeled nanoliposomes show efficacy in rat models of leptomeningeal disease

Read More

New delivery system SENDs therapeutic RNA without triggering immune system

Read More

Small-molecule degrader targets phospho-AKT and inhibits growth of PI3K/PTEN pathway mutant cancers

Read More

H3.3-K27M drives tumorigenesis in hindbrain NSCs through disruption of PRC2 and enhancer functions

Read More

Foghorn initiates first-in-human study of FHD-609 for synovial sarcoma

Read More

First-in-human data reported for [68Ga]iPSMA-BN in healthy subjects

Read More

Phase IIb study of izencitinib in ulcerative colitis misses primary endpoint

Read More

Bristol Myers Squibb identifies new lead BRD4 inhibitors

Read More

Completed phase I studies of ME-3183 pave way for phase II studies in plaque psoriasis

Read More

JadiCells show promise in animal model of COPD

Read More

Hepagene reports phase I data on FXR agonist HPG-1860

Read More

Jupiter Wellness submits pre-IND meeting request for JW-100 for eczema

Read More

Biallelic mutations in DNAH10 cause male infertility with asthenoteratozoospermia

Read More

BlueWillow announces interim phase I data on intranasal anthrax vaccine candidate BW-1010

Read More

Regeneron reports topline phase II results on 8-mg dose of aflibercept in wet AMD

Read More